SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anna Moles, Lindsay Murphy, Caroline L. Wilson, Jayashree Bagchi Chakraborty, Christopher Fox, Eek Joong Park, Jelena Mann, Fiona Oakley, Rachel Howarth, John Brain, Steven Masson, Michael Karin, Ekihiro Seki, Derek A. Mann, A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse, Journal of Hepatology, 2014, 60, 4, 782

    CrossRef

  2. 2
    Fabio Marra, Angela Provenzano, Elisa Vivoli, Mechanisms of Fibrosis in Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 142

    CrossRef

  3. 3
    Caroline C. Duwaerts, Jacquelyn J. Maher, Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 119

    CrossRef

  4. 4
    Duarte M. S. Ferreira, André L. Simão, Cecília M. P. Rodrigues, Rui E. Castro, Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease, FEBS Journal, 2014, 281, 11
  5. 5
    Adam C. Labonte, Annie-Carole Tosello-Trampont, Young S. Hahn, The Role of Macrophage Polarization in Infectious and Inflammatory Diseases, Molecules and Cells, 2014, 37, 4, 275

    CrossRef

  6. 6
    Lingling Ji, Ruyi Xue, Wenqing Tang, Weibin Wu, Tingting Hu, Xijun Liu, Xiaomin Peng, Jianxin Gu, She Chen, Si Zhang, Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways, FEBS Letters, 2014, 588, 12, 2095

    CrossRef

  7. 7
    Ling Yang, Yoon Seok Roh, Jingyi Song, Bi Zhang, Cheng Liu, Rohit Loomba, Ekihiro Seki, Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice, Hepatology, 2014, 59, 2
  8. 8
    Noga Budick-Harmelin, Michal Aharoni-Simon, Zecharia Madar, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  9. 9
    Christopher Depner, Kelli Lytle, Sasmita Tripathy, Donald Jump, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  10. 10
    Alexander Wree, Lori Broderick, Ali Canbay, Hal M. Hoffman, Ariel E. Feldstein, From NAFLD to NASH to cirrhosis—new insights into disease mechanisms, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 627

    CrossRef

  11. 11
    Michal Ganz, Gyongyi Szabo, Immune and inflammatory pathways in NASH, Hepatology International, 2013, 7, S2, 771

    CrossRef

  12. 12
    Xinshou Ouyang, Ayaz Ghani, Wajahat Z. Mehal, Inflammasome biology in fibrogenesis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 7, 979

    CrossRef

  13. 13
    Akinobu Takaki, Daisuke Kawai, Kazuhide Yamamoto, Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH), International Journal of Molecular Sciences, 2013, 14, 10, 20704

    CrossRef

  14. 14
    Akiko Eguchi, Davide Povero, Naim Alkhouri, Ariel E Feldstein, Novel therapeutic targets for nonalcoholic fatty liver disease, Expert Opinion on Therapeutic Targets, 2013, 17, 7, 773

    CrossRef

  15. 15
    C. Baldini, C. Rossi, F. Ferro, E. Santini, V. Seccia, V. Donati, A. Solini, The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome, Journal of Internal Medicine, 2013, 274, 5
  16. 16
    Yoon Seok Roh, Ekihiro Seki, Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, Journal of Gastroenterology and Hepatology, 2013, 28,